Literature DB >> 17446718

Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro.

Luca Dalle Carbonare1, Maria T Valenti, Francesco Bertoldo, Arianna Fracalossi, Elena Balducci, Giuseppe Azzarello, Orazio Vinante, Vincenzo Lo Cascio.   

Abstract

BACKGROUND AND AIMS: Human telomerase reverse transcriptase (hTERT) is the catalytic subunit of telomerase. hTERT expression and telomerase activity are elevated in most human tumors. Bisphosphonates play an important role in the management of tumors with the secondary involvement of bone.
METHODS: We investigated the effect on hTERT gene expression of clodronate, alendronate, and pamidronate (from 10(-6) M to 10(-5) M) on MCF-7 and T47D human breast cancer cells, using real time RTPCR.
RESULTS: At 10(-5) M, amino-bisphosphonates (alendronate and pamidronate) inhibited breast cancer cell viability and induced a significant decrease in hTERT gene expression with respect to controls (82% and 71% in MCF-7 cells; 74% and 60% in T47D, p<0.0001). No effect was observed with clodronate.
CONCLUSIONS: Amino-bisphosphonates down-regulate hTERT gene expression. The role of hTERT is a new finding, which gives an alternative explanation for the direct effect of bisphosphonates on tumor cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17446718     DOI: 10.1007/bf03324673

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  2 in total

1.  Runx2 expression: A mesenchymal stem marker for cancer.

Authors:  Maria Teresa Valenti; Paola Serafini; Giulio Innamorati; Anna Gili; Samuele Cheri; Claudio Bassi; Luca Dalle Carbonare
Journal:  Oncol Lett       Date:  2016-09-23       Impact factor: 2.967

2.  Physical Activity Prevents Cartilage Degradation: A Metabolomics Study Pinpoints the Involvement of Vitamin B6.

Authors:  Michela Deiana; Giovanni Malerba; Luca Dalle Carbonare; Samuele Cheri; Cristina Patuzzo; Grygoriy Tsenov; Lucas Moron Dalla Tor; Antonio Mori; Gianantonio Saviola; Donato Zipeto; Federico Schena; Monica Mottes; Maria Teresa Valenti
Journal:  Cells       Date:  2019-11-01       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.